Get the Stockscreener App
3.4542
0.72%
-0.0258
Sana Biotechnology Inc stock is traded at $3.4542, with a volume of 3.26M.
It is down -0.72% in the last 24 hours and up +2.83% over the past month.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
See More
Previous Close:
$3.48
Open:
$3.52
24h Volume:
3.26M
Relative Volume:
1.19
Market Cap:
$920.69M
Revenue:
-
Net Income/Loss:
$-244.17M
P/E Ratio:
-3.5381
EPS:
-0.9763
Net Cash Flow:
$-144.77M
1W Performance:
+7.63%
1M Performance:
+2.83%
6M Performance:
-41.64%
1Y Performance:
+103.24%
1-Day Range:
$3.33
$3.74
1-Week Range:
$3.05
$4.08
52-Week Range:
$1.53
$6.55
Sana Biotechnology Inc Stock (SANA) Company Profile
Name
Sana Biotechnology Inc
Sector
Industry
Phone
(206) 701-7914
Address
188 EAST BLAINE STREET, SUITE 350, SEATTLE
Compare SANA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.45 | 928.70M | 0 | -244.17M | -144.77M | -0.9763 |
VRTX
Vertex Pharmaceuticals Inc
|
442.41 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
748.47 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
842.97 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
334.65 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
317.28 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Initiated | Wedbush | Outperform |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Mar-18-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Mar-14-25 | Initiated | Jefferies | Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Nov-05-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Rodman & Renshaw | Buy |
| Jan-16-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-25-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-05-23 | Initiated | Citigroup | Buy |
| Aug-14-23 | Initiated | TD Cowen | Market Perform |
| May-02-23 | Initiated | H.C. Wainwright | Neutral |
| Mar-01-21 | Initiated | BofA Securities | Buy |
| Mar-01-21 | Initiated | Goldman | Neutral |
| Mar-01-21 | Initiated | JP Morgan | Neutral |
| Mar-01-21 | Initiated | Morgan Stanley | Overweight |
View All
Sana Biotechnology Inc Stock (SANA) Latest News
Sana Biotech rises as Mayo Clinic partners for diabetes therapy - MSN
Citizens reiterates Sana Biotechnology stock rating on Mayo deal By Investing.com - Investing.com Canada
Sana Biotechnology Inc. (SANA) hits new milestone on cell therapy for type 1 diabetes - MSN
Seattle InnoCajal raises $96M I Layoffs at Sana - The Business Journals
Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey (NASDAQ:SANA) - Seeking Alpha
SANA Stock Jumps As Mayo Clinic Backs Diabetes Cell Therapy - StocksToTrade
H.C. Wainwright reiterates Sana Biotechnology stock rating at buy By Investing.com - Investing.com Canada
Sana Biotech rises after Mayo Clinic deal (SANA:NASDAQ) - Seeking Alpha
Sana Biotechnology Inc. (SANA) Hits New Milestone on Cell Therapy for Type 1 Diabetes - Insider Monkey
Stock Market Today: Dow Jones, S&P 500 Futures Rise As JD Vance Touts 'Good Deal' If Iran Meets US 'Red Lines'—Sana, Chevron In Focus - Benzinga
Sana Biotechnology Announces Stock Purchase Agreement With Mayo Clinic for 7.5 Million Shares - Minichart
Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451 - Bitget
Sana VitaHoney Redefines Everyday Wellness with Portable Honey Spoon Innovation - openPR.com
Sana Biotechnology partners with Mayo Clinic on diabetes therapy By Investing.com - Investing.com India
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Sana Biotechnology IncSells 7.5 Million Shares To Mayo Clinic At $3.33 Per Share For $25 MillionSEC Filing - TradingView — Track All Markets
Sana Biotechnology and Mayo Clinic announce strategic collaboration focused on improving care in type 1 diabetes and accelerating development of SC451 - marketscreener.com
According to the latest disclosure filed with the US Securities and Exchange Commission, the biotechnology company Sana Biotechnology, Inc. has completed a significant equity transaction. - Bitget
Sana Biotechnology Secures Strategic Equity Investment from Mayo - TipRanks
Sana Biotechnology shares gain on Mayo Clinic partnership By Investing.com - Investing.com Canada
Sana Biotechnology partners with Mayo Clinic on diabetes therapy - Investing.com
SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company? - Stocktwits
Setup Watch: Is Sana Biotechnology Inc benefiting from interest rate changesWeekly Profit Recap & Capital Efficient Trading Techniques - baoquankhu1.vn
Merger Talk: Can Sana Biotechnology Inc maintain its current growth rateMarket Risk Report & Capital Protection Trade Alerts - baoquankhu1.vn
Sana Biotechnology Stock Short Interest Rises to 46.21% - Moomoo
Director at Sana Biotechnology (SANA) granted 7,763 fully vested RSUs - Stock Titan
Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines - Sahm
Earnings Miss: Is Sana Biotechnology Inc in a long term uptrendWeekly Investment Recap & Fast Moving Stock Trade Plans - baoquankhu1.vn
InvestingPro’s Fair Value spotted Sana Biotech overvaluation early By Investing.com - Investing.com Australia
Growth Recap: What are Sana Biotechnology Incs earnings expectationsMarket Volume Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
SANA Forecast, Price Target & Analyst Ratings | SANA BIOTECHNOLOGY INC (NASDAQ:SANA) - ChartMill
SANA PE Ratio & Valuation, Is SANA Overvalued - Intellectia AI
JPMorgan Chase & Co. Raises Holdings in Sana Biotechnology, Inc. $SANA - MarketBeat
Sana Biotechnology Inc. (SANA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Citi Maintained a Buy Rating on Sana Biotechnology (SANA) - MSN
Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’ - MSN
Options Flow: Is Sana Biotechnology Inc a stock for growth or value investorsQuarterly Trade Summary & Expert Approved Momentum Ideas - baoquankhu1.vn
Aug Breakouts: How does Sana Biotechnology Inc score in quality rankingsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Sana Biotechnology (NASDAQ: SANA) EVP files initial ownership report - Stock Titan
Sana Biotechnology (NASDAQ:SANA) Trading Down 7.2%Here's What Happened - MarketBeat
Shorts Report: How does Sana Biotechnology Inc score in quality rankingsMarket Sentiment Review & Accurate Intraday Trade Tips - baoquankhu1.vn
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
SANA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Sana Biotechnology (SANA) appoints industry veteran Brian Piper as new CFO - MSN
Bull Run: Will Sana Biotechnology Inc stock hit new highs in YEAR2026 Outlook & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Breakouts Watch: Can Sana Biotechnology Inc be the next market leaderDay Trade & High Accuracy Buy Signal Tips - baoquankhu1.vn
H.C. Wainwright reiterates Sana Biotechnology stock buy rating - Investing.com
Sana Biotechnology reports 14-month data on diabetes cell therapy By Investing.com - Investing.com India
Integral Health Asset Management LLC Has $7.10 Million Stock Position in Sana Biotechnology, Inc. $SANA - MarketBeat
Morgan Stanley Maintains Overweight on Sana Biotechnology, Inc. (SANA) March 2026 - Meyka
Sana Biotechnology Inc Stock (SANA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sana Biotechnology Inc Stock (SANA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Harr Steve | President & CEO |
Mar 06 '26 |
Option Exercise |
0.00 |
41,666 |
0 |
7,918,596 |
| Wyrick Susan D. | See Remarks |
Mar 07 '26 |
Option Exercise |
0.00 |
3,250 |
0 |
200,583 |
| Wyrick Susan D. | See Remarks |
Mar 06 '26 |
Option Exercise |
0.00 |
10,416 |
0 |
197,333 |
| Wyrick Susan D. | See Remarks |
Mar 02 '26 |
Option Exercise |
0.00 |
1,525 |
0 |
187,408 |
| Wyrick Susan D. | See Remarks |
Jan 02 '26 |
Option Exercise |
0.00 |
7,500 |
0 |
188,290 |
| Wyrick Susan D. | See Remarks |
Dec 13 '25 |
Option Exercise |
0.00 |
3,400 |
0 |
181,663 |
| Wyrick Susan D. | See Remarks |
Dec 03 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
180,828 |
| Wyrick Susan D. | See Remarks |
Jun 03 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
170,395 |
2.68%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):